Streetbeat News

Products Services

FCOM

META

MTCH

XLC

Meta Platforms Inc. introduced a 'Hidden Words' feature on Threads, allowing users to filter offensive content. Match Group's Hinge also launched a similar feature. Threads is enhancing user control with additional functionalities, including post quoting controls and notification muting. Meta's Threads has reached over 150 million monthly active users. The FTC is probing Meta's privacy practices, focusing on minors' data and facial recognition technology. Meta will shut down Threads in Turkey due to regulatory issues and has delayed its EU launch. Meta's stock has gained 111% over the last year, with exposure available through XLC and FCOM ETFs.

Portfolio Pulse from Anusuya Lahiri

April 26, 2024 | 12:34 pm

TAK

Takeda's fruquintinib received a positive CHMP opinion for treating metastatic colorectal cancer in the EU, marking it as the first novel targeted therapy in over a decade. The recommendation is based on Phase 3 trial results showing significant survival benefits. The European Commission will next review the CHMP's recommendation for final approval.

Portfolio Pulse from Benzinga Newsdesk

April 26, 2024 | 12:32 pm

SNY

Sobi announced that the CHMP of the European Medicines Agency has recommended approval of efanesoctocog alfa for haemophilia A treatment. This once-weekly therapy has shown significant improvements in bleed protection and quality of life in clinical studies. Efanesoctocog alfa was approved in the US by the FDA in February 2023, having received Breakthrough Therapy, Fast Track, and Orphan Drug designations.

Portfolio Pulse from Benzinga Newsdesk

April 26, 2024 | 12:07 pm

GILD

The FDA has approved an updated label for Gilead Sciences' Biktarvy, including additional data supporting its safety and efficacy for treating pregnant adults with HIV-1. This makes Biktarvy the only second-generation integrase strand transfer inhibitor (INSTI)-based single-tablet regimen with FDA approval for this group. The update is based on Study 5310, which showed maintained viral suppression and no new safety concerns during and post-pregnancy. The DHHS perinatal guidelines now recommend Biktarvy as an alternative regimen for pregnancy and conception.

Portfolio Pulse from Benzinga Newsdesk

April 26, 2024 | 12:05 pm

MDT

Medtronic announced FDA approval for its Inceptiv closed-loop spinal cord stimulator, designed to treat chronic pain by automatically adjusting stimulation based on biological signals. This is the first Medtronic SCS device with such a feature, enhancing therapy alignment with daily activities.

Portfolio Pulse from Benzinga Newsdesk

April 26, 2024 | 11:58 am

TSLA

At the Orlando Airshow, Tesla's Cybertruck raced against a World War 2-era QuickSilver P-51 Mustang and was defeated, as expected due to the vast difference in top speeds. Despite the loss, Tesla CEO Elon Musk reacted positively, calling it 'cool.' Additionally, Tesla recently recalled 3,878 Cybertruck vehicles due to concerns over unintentional acceleration, with plans to repair or replace the accelerator pedal assembly at no cost. Tesla aims to ramp up Cybertruck production to deliver 250,000 units annually by 2025.

Portfolio Pulse from Anan Ashraf

April 26, 2024 | 11:53 am

AAPL

GOOG

MSFT

Jim Cramer criticized the media for focusing too much on Apple's challenges, such as antitrust issues and declining iPhone sales in China, while underreporting Alphabet's and Microsoft's strong quarterly earnings. Alphabet and Microsoft exceeded expectations, while Apple's iPhone sales in China fell by 19.1%, marking its worst performance since 2020. This comes as Wall Street looks forward to Apple's Q2 earnings, with a positive outlook despite recent struggles.

Portfolio Pulse from Benzinga Neuro

April 26, 2024 | 11:42 am

MDB

MSFT

SNOW

Microsoft Corp. (NASDAQ:MSFT) reported strong Q3 results, attributed to its Cloud business, with Azure's revenue up 23% year-over-year. Analyst Brent Bracelin highlighted Azure's performance, particularly in AI, as exceeding expectations and noted Snowflake, Inc. (NYSE:SNOW) and MongoDB, Inc. (NASDAQ:MDB) as companies to watch due to their indirect exposure to Azure's success. Following the report, MSFT, SNOW, and MDB stocks all saw premarket trading increases.

Portfolio Pulse from Shanthi Rexaline

April 26, 2024 | 11:41 am

VMAR

Vision Marine Technologies announced the filing of a patent for an advanced system communication encryption in its E-Motion powertrain, aimed at enhancing security, ensuring system conformity, and improving the boating experience.

Portfolio Pulse from Benzinga Newsdesk

April 26, 2024 | 11:40 am

OPRX

OptimizeRx Corporation (OPRX) forecasts a significant revenue increase of over 40% YoY for 1Q24, expecting to achieve $18.5M-$19.2M, surpassing the $17.03M estimate. This growth is attributed to strong organic growth from its Dynamic Audience Activation Platform (DAAP) and the acquisition of Medicx Health in October 2023. The company also reports progress in commercial integration and cross-selling activities with Medicx, highlighting a potential $2.8 billion opportunity with existing brands. Despite the revenue growth, OPRX anticipates a GAAP net loss and Adjusted EBITDA loss for the quarter.

Portfolio Pulse from Benzinga Newsdesk

April 26, 2024 | 11:37 am